News
Videos
Conferences
Events
Resources
Subscribe

|Videos|September 18, 2015

Prostate Cancer Staging

Episodes in this series

EP. 1 Understanding Prostate Cancer Grade and Stage

EP. 1 Understanding Prostate Cancer Grade and Stage

EP. 2 Getting a Second Opinion on Your Biopsy Report

EP. 2 Getting a Second Opinion on Your Biopsy Report

EP. 3 Prostate Cancer Staging

EP. 3 Prostate Cancer Staging

EP. 4 Multidisciplinary Care for Prostate Cancer

EP. 4 Multidisciplinary Care for Prostate Cancer

EP. 5 Patient With Metastatic Prostate Cancer

EP. 5 Patient With Metastatic Prostate Cancer

EP. 6 Patient With Locally Advanced Prostate Cancer

EP. 6 Patient With Locally Advanced Prostate Cancer

EP. 7 Reliable Information About Prostate Cancer

EP. 7 Reliable Information About Prostate Cancer

EP. 8 New Drugs for Advanced Prostate Cancer

EP. 8 New Drugs for Advanced Prostate Cancer

EP. 9 Do You Have the Right Doctor?

EP. 9 Do You Have the Right Doctor?

EP. 10 Prostate Cancer Awareness

EP. 10 Prostate Cancer Awareness

Newsletter

Stay up to date on cancer updates, research and education

Related Content

FDA Approves Stoboclo and Osenvelt as Biosimilars for Some Cancers

BySpencer Feldman

November 3rd 2025

Choosing treatment for stage 2 prostate cancer? Get the facts on surgery vs. radiation and learn to manage possible side effects like erectile dysfunction.

What Does a Stage 2 Prostate Cancer Diagnosis Mean for Me?

November 2nd 2025

prostate cancer

Alternative Docetaxel Dosing Reduces Toxicity Risk in Prostate Cancer

ByBenjamin P. Saylor

October 22nd 2025

Image of Prostate.

Supplemental Xtandi Does Not Improve Metastasis-Free Survival in High-Risk Prostate Cancer

October 19th 2025

Adding Truqap to Zytiga, prednisone, and ADT extended radiographic progression-free survival by 7.5 months in PTEN-deficient prostate cancer.

Truqap Extends Radiographic Progression-Free Survival in Some With Prostate Cancer

October 19th 2025

Trending on CURE

Top Breast Cancer Stories from October 2025

Top Gastrointestinal Cancer News: October 2025

FDA Grants Orphan Drug Designation to M2T-CD33 in AML

Hairy Cell Leukemia Experts Impart Advice on Care and Support

Brachytherapy, Chemo, and Turner Syndrome: A Teen's Rare Cancer Battle

© 2025 MJH Life Sciences^®

All rights reserved.